https://stock.noler.com/us/stock/evoke-pharma-inc https://stock.noler.com/us/stock/evoke-pharma-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/evoke-pharma-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/evoke-pharma-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/evoke-pharma-inc/accounts-receivable https://stock.noler.com/us/stock/evoke-pharma-inc/accrued-payroll-taxes-current https://stock.noler.com/us/stock/evoke-pharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/evoke-pharma-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/evoke-pharma-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/evoke-pharma-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/evoke-pharma-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/evoke-pharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/evoke-pharma-inc/basic-shares https://stock.noler.com/us/stock/evoke-pharma-inc/bridge-loan https://stock.noler.com/us/stock/evoke-pharma-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/evoke-pharma-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/evoke-pharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/evoke-pharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/evoke-pharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/evoke-pharma-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/evoke-pharma-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/evoke-pharma-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/evoke-pharma-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/evoke-pharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/evoke-pharma-inc/common-stock-value https://stock.noler.com/us/stock/evoke-pharma-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/evoke-pharma-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/evoke-pharma-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/evoke-pharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/evoke-pharma-inc/current-assets https://stock.noler.com/us/stock/evoke-pharma-inc/current-liabilities https://stock.noler.com/us/stock/evoke-pharma-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/evoke-pharma-inc/debt-carrying-amount https://stock.noler.com/us/stock/evoke-pharma-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/evoke-pharma-inc/debt-fee-amount https://stock.noler.com/us/stock/evoke-pharma-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/evoke-pharma-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/evoke-pharma-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/evoke-pharma-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/evoke-pharma-inc/debt-unamortized-discount https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-costs https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-offering-costs https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/evoke-pharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/evoke-pharma-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/evoke-pharma-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/evoke-pharma-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/evoke-pharma-inc/diluted-shares https://stock.noler.com/us/stock/evoke-pharma-inc/dilutive-shares https://stock.noler.com/us/stock/evoke-pharma-inc/dividends-common-stock-cash https://stock.noler.com/us/stock/evoke-pharma-inc/dividends-per-share https://stock.noler.com/us/stock/evoke-pharma-inc/due-to-officers-or-stockholders-current-and-noncurrent https://stock.noler.com/us/stock/evoke-pharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/evoke-pharma-inc/effective-tax-rate https://stock.noler.com/us/stock/evoke-pharma-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/evoke-pharma-inc/eps https://stock.noler.com/us/stock/evoke-pharma-inc/eps-basic https://stock.noler.com/us/stock/evoke-pharma-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/evoke-pharma-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/evoke-pharma-inc/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/evoke-pharma-inc/financing-cash-flow https://stock.noler.com/us/stock/evoke-pharma-inc/form-d-stocks https://stock.noler.com/us/stock/evoke-pharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/evoke-pharma-inc/income-tax-examination-liability-refund-adjustment-from-settlement-with-taxing-authority https://stock.noler.com/us/stock/evoke-pharma-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/evoke-pharma-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/evoke-pharma-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/evoke-pharma-inc/insider-transactions-other https://stock.noler.com/us/stock/evoke-pharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/evoke-pharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/evoke-pharma-inc/insider-transactions-warrants https://stock.noler.com/us/stock/evoke-pharma-inc/interest-expense https://stock.noler.com/us/stock/evoke-pharma-inc/interest-expense-long-term-debt https://stock.noler.com/us/stock/evoke-pharma-inc/interest-expense-other https://stock.noler.com/us/stock/evoke-pharma-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/evoke-pharma-inc/interest-income-other https://stock.noler.com/us/stock/evoke-pharma-inc/interest-paid https://stock.noler.com/us/stock/evoke-pharma-inc/interest-payable-current https://stock.noler.com/us/stock/evoke-pharma-inc/interest-receivable https://stock.noler.com/us/stock/evoke-pharma-inc/inventory https://stock.noler.com/us/stock/evoke-pharma-inc/inventory-finished-goods https://stock.noler.com/us/stock/evoke-pharma-inc/inventory-raw-materials https://stock.noler.com/us/stock/evoke-pharma-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/evoke-pharma-inc/inventory-work-in-process https://stock.noler.com/us/stock/evoke-pharma-inc/inventory-write-down https://stock.noler.com/us/stock/evoke-pharma-inc/investment-income-interest https://stock.noler.com/us/stock/evoke-pharma-inc/investment-income-nonoperating https://stock.noler.com/us/stock/evoke-pharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/evoke-pharma-inc/lease-cost https://stock.noler.com/us/stock/evoke-pharma-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/evoke-pharma-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/evoke-pharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/evoke-pharma-inc/level-3-liability-issues https://stock.noler.com/us/stock/evoke-pharma-inc/liabilities-noncurrent https://stock.noler.com/us/stock/evoke-pharma-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/evoke-pharma-inc/line-of-credit-facility-current-borrowing-capacity https://stock.noler.com/us/stock/evoke-pharma-inc/line-of-credit-facility-increase-accrued-interest https://stock.noler.com/us/stock/evoke-pharma-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/evoke-pharma-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/evoke-pharma-inc/loans-assumed https://stock.noler.com/us/stock/evoke-pharma-inc/long-term-debt https://stock.noler.com/us/stock/evoke-pharma-inc/long-term-notes-payable https://stock.noler.com/us/stock/evoke-pharma-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/evoke-pharma-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/evoke-pharma-inc/net-change-in-cash https://stock.noler.com/us/stock/evoke-pharma-inc/net-income https://stock.noler.com/us/stock/evoke-pharma-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/evoke-pharma-inc/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/evoke-pharma-inc/notes-payable-current https://stock.noler.com/us/stock/evoke-pharma-inc/number-of-operating-segments https://stock.noler.com/us/stock/evoke-pharma-inc/operating-cash-flow https://stock.noler.com/us/stock/evoke-pharma-inc/operating-expenses https://stock.noler.com/us/stock/evoke-pharma-inc/operating-income https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-assets https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-expense https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-liability https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-payments https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/evoke-pharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/evoke-pharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/evoke-pharma-inc/other-current-assets https://stock.noler.com/us/stock/evoke-pharma-inc/other-current-liabilities https://stock.noler.com/us/stock/evoke-pharma-inc/other-income https://stock.noler.com/us/stock/evoke-pharma-inc/other-noncash-expense https://stock.noler.com/us/stock/evoke-pharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/evoke-pharma-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/evoke-pharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/evoke-pharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/evoke-pharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/evoke-pharma-inc/paid-in-kind-interest https://stock.noler.com/us/stock/evoke-pharma-inc/payments-for-repurchase-of-initial-public-offering https://stock.noler.com/us/stock/evoke-pharma-inc/payments-for-underwriting-expense https://stock.noler.com/us/stock/evoke-pharma-inc/payments-of-loan-costs https://stock.noler.com/us/stock/evoke-pharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/evoke-pharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/evoke-pharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/evoke-pharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/evoke-pharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/evoke-pharma-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/evoke-pharma-inc/preferred-stock-value https://stock.noler.com/us/stock/evoke-pharma-inc/prepaid-expense-current https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-issuance-of-unsecured-debt https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/evoke-pharma-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/evoke-pharma-inc/provision-for-loan-losses-expensed https://stock.noler.com/us/stock/evoke-pharma-inc/public-float https://stock.noler.com/us/stock/evoke-pharma-inc/receivables-net-current https://stock.noler.com/us/stock/evoke-pharma-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/evoke-pharma-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/evoke-pharma-inc/research-and-development https://stock.noler.com/us/stock/evoke-pharma-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/evoke-pharma-inc/research-and-development-in-process https://stock.noler.com/us/stock/evoke-pharma-inc/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/evoke-pharma-inc/retained-earnings https://stock.noler.com/us/stock/evoke-pharma-inc/revenue https://stock.noler.com/us/stock/evoke-pharma-inc/revenue-from-grants https://stock.noler.com/us/stock/evoke-pharma-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/evoke-pharma-inc/sga-expense https://stock.noler.com/us/stock/evoke-pharma-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/evoke-pharma-inc/shareholders-equity https://stock.noler.com/us/stock/evoke-pharma-inc/shares-authorized https://stock.noler.com/us/stock/evoke-pharma-inc/shares-issued https://stock.noler.com/us/stock/evoke-pharma-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/evoke-pharma-inc/short-term-lease-cost https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/evoke-pharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/evoke-pharma-inc/stock-based-compensation https://stock.noler.com/us/stock/evoke-pharma-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/evoke-pharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/evoke-pharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/evoke-pharma-inc/stock-issued-shares-issued-shares-change https://stock.noler.com/us/stock/evoke-pharma-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/evoke-pharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/evoke-pharma-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/evoke-pharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-grants-in-period-grant-date-intrinsic-value https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/evoke-pharma-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/evoke-pharma-inc/stock-split-ratio https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-deductions https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/evoke-pharma-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/evoke-pharma-inc/total-assets https://stock.noler.com/us/stock/evoke-pharma-inc/total-liabilities https://stock.noler.com/us/stock/evoke-pharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/evoke-pharma-inc/total-long-term-debt https://stock.noler.com/us/stock/evoke-pharma-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/evoke-pharma-inc/utb-change https://stock.noler.com/us/stock/evoke-pharma-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/evoke-pharma-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/evoke-pharma-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/evoke-pharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/evoke-pharma-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/evoke-pharma-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/evoke-pharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/evoke-pharma-inc/weighted-average-number-of-shares-common-stock-subject-to-repurchase-or-cancellation